SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-21-054675
Filing Date
2021-02-24
Accepted
2021-02-24 16:22:42
Documents
112
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d105808d10k.htm   iXBRL 10-K 2379588
2 EX-21.1 d105808dex211.htm EX-21.1 10748
3 EX-23.1 d105808dex231.htm EX-23.1 4397
4 EX-31.1 d105808dex311.htm EX-31.1 10590
5 EX-31.2 d105808dex312.htm EX-31.2 10588
6 EX-32.1 d105808dex321.htm EX-32.1 6541
12 GRAPHIC g105808g19j62.jpg GRAPHIC 44976
  Complete submission text file 0001193125-21-054675.txt   12373568

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rgen-20201231.xsd EX-101.SCH 78312
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20201231_cal.xml EX-101.CAL 77453
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20201231_def.xml EX-101.DEF 659795
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20201231_lab.xml EX-101.LAB 730934
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20201231_pre.xml EX-101.PRE 719494
13 EXTRACTED XBRL INSTANCE DOCUMENT d105808d10k_htm.xml XML 2232617
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14656 | Film No.: 21673544
SIC: 2836 Biological Products, (No Diagnostic Substances)